Interstitial Lung Disease

Welcome to the Interstitial Lung Disease(ILD) Program, a subspecialty clinic within the Emory Advanced Lung Disease Center.

Mission Statement: To provide a comprehensive program dedicated to the care of patients with interstitial lung disease which encompasses accurate diagnosis, treatment, research, support and lung transplantation in a multidisciplinary setting.

What is ILD?

ILD is a varied group of lung diseases, many of which result in permanent scarring or "fibrosis" of the lung tissue. There are nearly 200 distinct diseases, though only a handful of them are common. While some are known to result from exposure to hazardous substances in the environment (eg, asbestos, coal, and tobacco smoke), often no identifiable cause can be attributed to the development of the disease (termed idiopathic). Lung fibrosis can also be a feature of connective tissue diseases such as Rheumatoid Arthritis, Scleroderma and certain forms of vasculitis.

Treatment options and prognosis vary dramatically by cause, thus a thorough evaluation is integral to:

  1. Confirming the diagnosis.
  2. Identifying the cause.
  3. Formulating an effective treatment plan.

These crucial tasks are the main focus of our program, and are accomplished through collaboration with the departments of Pathology, Radiology and Thoracic Surgery.